Cargando…

Global site-specific N-glycosylation analysis of HIV envelope glycoprotein

HIV-1 envelope glycoprotein (Env) is the sole target for broadly neutralizing antibodies (bnAbs) and the focus for design of an antibody-based HIV vaccine. The Env trimer is covered by ∼90N-linked glycans, which shield the underlying protein from immune surveillance. bNAbs to HIV develop during infe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cao, Liwei, Diedrich, Jolene K., Kulp, Daniel W., Pauthner, Matthias, He, Lin, Park, Sung-Kyu Robin, Sok, Devin, Su, Ching Yao, Delahunty, Claire M., Menis, Sergey, Andrabi, Raiees, Guenaga, Javier, Georgeson, Erik, Kubitz, Michael, Adachi, Yumiko, Burton, Dennis R., Schief, William R., Yates III, John R., Paulson, James C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5379070/ https://www.ncbi.nlm.nih.gov/pubmed/28348411 http://dx.doi.org/10.1038/ncomms14954

Ejemplares similares

Differential processing of HIV envelope glycans on the virus and soluble recombinant trimer
por: Cao, Liwei, et al.
Publicado: (2018)

Enhancing Humoral Responses Against HIV Envelope Trimers via Nanoparticle Delivery with Stabilized Synthetic Liposomes
por: Tokatlian, Talar, et al.
Publicado: (2018)

Structure-based design of native-like HIV-1 envelope trimers to silence non-neutralizing epitopes and eliminate CD4 binding
por: Kulp, Daniel W., et al.
Publicado: (2017)

Global site-specific analysis of glycoprotein N-glycan processing
por: Cao, Liwei, et al.
Publicado: (2018)

A Broadly Neutralizing Antibody Targets the Dynamic HIV Envelope Trimer Apex via a Long, Rigidified, and Anionic β-Hairpin Structure
por: Lee, Jeong Hyun, et al.
Publicado: (2017)

Evolving spike-protein N-glycosylation in SARS-CoV-2 variants
por: Baboo, Sabyasachi, et al.
Publicado: (2023)

Tailored Immunogens Direct Affinity Maturation toward HIV Neutralizing Antibodies
por: Briney, Bryan, et al.
Publicado: (2016)

Autologous Antibody Responses to an HIV Envelope Glycan Hole Are Not Easily Broadened in Rabbits
por: Yang, Yuhe R., et al.
Publicado: (2020)

Site-specific O-glycosylation analysis of SARS-CoV-2 spike protein produced in insect and human cells
por: Bagdonaite, Ieva, et al.
Publicado: (2021)

Site-Specific O-Glycosylation Analysis of SARS-CoV-2 Spike Protein Produced in Insect and Human Cells
por: Bagdonaite, Ieva, et al.
Publicado: (2021)

Human immunoglobulin repertoire analysis guides design of vaccine priming immunogens targeting HIV V2-apex broadly neutralizing antibody precursors
por: Willis, Jordan R., et al.
Publicado: (2022)

The Chimpanzee SIV Envelope Trimer: Structure and Deployment as an HIV Vaccine Template
por: Andrabi, Raiees, et al.
Publicado: (2019)

Comparative membrane proteomics reveals diverse cell regulators concentrated at the nuclear envelope
por: Cheng, Li-Chun, et al.
Publicado: (2023)

Comparative membrane proteomics reveals diverse cell regulators concentrated at the nuclear envelope
por: Cheng, Li-Chun, et al.
Publicado: (2023)

RosettaAntibodyDesign (RAbD): A general framework for computational antibody design
por: Adolf-Bryfogle, Jared, et al.
Publicado: (2018)

HIV envelope trimer-elicited autologous neutralizing antibodies bind a region overlapping the N332 glycan supersite
por: Nogal, Bartek, et al.
Publicado: (2020)

Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model
por: Voss, James E., et al.
Publicado: (2017)

Elicitation of Neutralizing Antibodies Targeting the V2 Apex of the HIV Envelope Trimer in a Wild-Type Animal Model
por: Voss, James E., et al.
Publicado: (2018)

An HIV-1 Envelope Glycoprotein Trimer with an Embedded IL-21 Domain Activates Human B Cells
por: Isik, Gözde, et al.
Publicado: (2013)

Elicitation of Robust Tier 2 Neutralizing Antibody Responses in Nonhuman Primates by HIV Envelope Trimer Immunization Using Optimized Approaches
por: Pauthner, Matthias, et al.
Publicado: (2017)

Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design
por: Irimia, Adriana, et al.
Publicado: (2017)

Exploitation of glycosylation in enveloped virus pathobiology
por: Watanabe, Yasunori, et al.
Publicado: (2019)

Correction: Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design
por: Jardine, Joseph G., et al.
Publicado: (2016)

Minimally Mutated HIV-1 Broadly Neutralizing Antibodies to Guide Reductionist Vaccine Design
por: Jardine, Joseph G., et al.
Publicado: (2016)

HIV Vaccine Design to Target Germline Precursors of Glycan-Dependent Broadly Neutralizing Antibodies
por: Steichen, Jon M., et al.
Publicado: (2016)

Interactome analysis illustrates diverse gene regulatory processes associated with LIN28A in human iPS cell-derived neural progenitor cells
por: Yu, Nam-Kyung, et al.
Publicado: (2021)

Human Influenza Virus Hemagglutinins Contain Conserved Oligomannose N-Linked Glycans Allowing Potent Neutralization by Lectins
por: Thompson, Andrew J., et al.
Publicado: (2020)

HIV-1 Envelope Glycosylation and the Signal Peptide
por: Lambert, Gregory S., et al.
Publicado: (2021)

Cross clade reactive plasma anti-V3 antibodies in human immunodeficiency virus type-1 infected individuals develop with time
por: Andrabi, Raiees, et al.
Publicado: (2012)

Characterization of human anti-V3 monoclonal antibody 904 isolated from an Indian clade C Human Immunodeficiency Virus type-1 (HIV-1) infected donor
por: Andrabi, Raiees, et al.
Publicado: (2013)

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120
por: Kong, Leopold, et al.
Publicado: (2013)

Engineering HIV envelope protein to activate germline B cell receptors of broadly neutralizing anti-CD4 binding site antibodies
por: McGuire, Andrew T., et al.
Publicado: (2013)

Generation and characterization of human monoclonal single chain variable fragments (scFvs) against envelope third variable region (V3) of HIV-1 clade C
por: Kumar, Rajesh, et al.
Publicado: (2012)

Cross-editing by a tRNA synthetase allows vertebrates to abundantly express mischargeable tRNA without causing mistranslation
por: Chen, Meirong, et al.
Publicado: (2020)

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021)

Differences in the Binding Affinity of an HIV-1 V2 Apex-Specific Antibody for the SIV(smm/mac) Envelope Glycoprotein Uncouple Antibody-Dependent Cellular Cytotoxicity from Neutralization
por: von Bredow, Benjamin, et al.
Publicado: (2019)

Mechanism-Based Post-Translational Modification and Inactivation in Terpene Synthases
por: Kersten, Roland D., et al.
Publicado: (2015)

Disassembly of HIV envelope glycoprotein trimer immunogens is driven by antibodies elicited via immunization
por: Turner, Hannah L., et al.
Publicado: (2021)

Subtle evolutionary changes in the distribution of N-glycosylation sequons in the HIV-1 envelope glycoprotein 120
por: Rao, R. Shyama Prasad, et al.
Publicado: (2010)

Hyper-replicative bovine leukemia virus by mutation of an envelope N-linked glycosylation site
por: de Brogniez, A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_n5skvbk1i7grk3n6b4vh7ptmau